SARS-COV-2 and COVID-19 - A Randomized controlled trail (unblinded)

Effectivenss of an Siddha treatment approach in SARS-COV-2 and COVID-19 - A Randomized controlled trail (Unblinded) at Govt. Kipauk Medical College, Chennai-10

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027033

Enrollment

100

Registered

2020-08-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Nilavembu kudineer Kabasura kudineer Thippili rasayanam Aadathodai manapagu Swasakudori maathirai Thoothuvalai legiyam Amukara chooranam Seenilnthil chooranam Pavala parpam Silasathu pa

Eligibility

Inclusion criteria

Inclusion criteria: Rt-PCR positive patients, Asymptomatic patients, Fever, Dry cough, Sore throat, Difficulty in breathing

Exclusion criteria

Exclusion criteria: Bronchogeniccarcinoma, Pulmonary TB, Pregnancy and lactating mothers, Status asthmatics

Design outcomes

Primary

Measure	Time frame
Outcomes is mainly assessed by reduction in Clinical symptoms and Rt-PCR test NegativeTimepoint: 3 Months	—

Secondary

Measure	Time frame
Outcomes is mainly assessed by reduction in Clinical symptoms and Rt-PCR test Negative The outcome is assessed by patients recovery progress with faster reductions in clinical symptoms and Rt-PCR test negative,also to avoid the mortality rate by administering Allopathy and Siddha medicines for the easy recovery and saftety measures in the treatment for SARS-CoV-2 and COVID-19.Timepoint: 3 Months	—

Countries

India

Contacts

Public ContactDr A Shiyam ranjith

Government Siddha Medical College

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026